121 related articles for article (PubMed ID: 1429227)
1. Reveromycins, new inhibitors of eukaryotic cell growth. III. Structures of reveromycins A, B, C and D.
Koshino H; Takahashi H; Osada H; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1420-7. PubMed ID: 1429227
[TBL] [Abstract][Full Text] [Related]
2. Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties.
Takahashi H; Osada H; Koshino H; Kudo T; Amano S; Shimizu S; Yoshihama M; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1409-13. PubMed ID: 1429225
[TBL] [Abstract][Full Text] [Related]
3. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor.
Osada H; Koshino H; Isono K; Takahashi H; Kawanishi G
J Antibiot (Tokyo); 1991 Feb; 44(2):259-61. PubMed ID: 2010365
[No Abstract] [Full Text] [Related]
4. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities.
Takahashi H; Osada H; Koshino H; Sasaki M; Onose R; Nakakoshi M; Yoshihama M; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1414-9. PubMed ID: 1429226
[TBL] [Abstract][Full Text] [Related]
5. Reveromycins revealed: new polyketide spiroketals from Australian marine-derived and terrestrial Streptomyces spp. A case of natural products vs. artifacts.
Fremlin L; Farrugia M; Piggott AM; Khalil Z; Lacey E; Capon RJ
Org Biomol Chem; 2011 Feb; 9(4):1201-11. PubMed ID: 21152660
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective synthesis of the [6,6] spiroketal core of reveromycin A.
Drouet KE; Ling T; Tran HV; Theodorakis EA
Org Lett; 2000 Jan; 2(2):207-10. PubMed ID: 10814283
[TBL] [Abstract][Full Text] [Related]
7. The structure of tautomycin, a dialkylmaleic anhydride antibiotic.
Cheng XC; Ubukata M; Isono K
J Antibiot (Tokyo); 1990 Jul; 43(7):809-19. PubMed ID: 2387775
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of reveromycin A.
Shimizu T; Masuda T; Hiramoto K; Nakata T
Org Lett; 2000 Jul; 2(14):2153-6. PubMed ID: 10891254
[TBL] [Abstract][Full Text] [Related]
9. Chemical modification of reveromycin A and its biological activities.
Shimizu T; Usui T; Machida K; Furuya K; Osada H; Nakata T
Bioorg Med Chem Lett; 2002 Dec; 12(23):3363-6. PubMed ID: 12419362
[TBL] [Abstract][Full Text] [Related]
10. Short synthesis of the 6,6-spiroketal cores of spirofungins A and B.
Dias LC; de Oliveira LG
Org Lett; 2004 Jul; 6(15):2587-90. PubMed ID: 15255697
[TBL] [Abstract][Full Text] [Related]
11. Heliquinomycin, a new inhibitor of DNA helicase, produced by Streptomyces sp. MJ929-SF2 II. Structure determination of heliquinomycin.
Chino M; Nishikawa K; Tsuchida T; Sawa R; Nakamura H; Nakamura KT; Muraoka Y; Ikeda D; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1997 Feb; 50(2):143-6. PubMed ID: 9099224
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
Shimizu T; Usui T; Fujikura M; Kawatani M; Satoh T; Machida K; Kanoh N; Woo JT; Osada H; Sodeoka M
Bioorg Med Chem Lett; 2008 Jul; 18(13):3756-60. PubMed ID: 18519164
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective total synthesis of reveromycin B and C19-epi-reveromycin B.
Drouet KE; Theodorakis EA
Chemistry; 2000 Jun; 6(11):1987-2001. PubMed ID: 10894398
[TBL] [Abstract][Full Text] [Related]
14. Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties.
Fehr T; Kallen J; Oberer L; Sanglier JJ; Schilling W
J Antibiot (Tokyo); 1999 May; 52(5):474-9. PubMed ID: 10480571
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of (-)-reveromycin B.
Cuzzupe AN; Hutton CA; Lilly MJ; Mann RK; Rizzacasa MA; Zammit SC
Org Lett; 2000 Jan; 2(2):191-4. PubMed ID: 10814279
[TBL] [Abstract][Full Text] [Related]
16. 16-Methyloxazolomycin, a new antimicrobial and cytotoxic substance produced by a Streptomyces sp.
Ryu G; Hwang S; Kim SK
J Antibiot (Tokyo); 1997 Dec; 50(12):1064-6. PubMed ID: 9510916
[No Abstract] [Full Text] [Related]
17. Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B.
Cuzzupe AN; Hutton CA; Lilly MJ; Mann RK; McRae KJ; Zammit SC; Rizzacasa MA
J Org Chem; 2001 Apr; 66(7):2382-93. PubMed ID: 11281779
[TBL] [Abstract][Full Text] [Related]
18. Structure of the new spiroketal-macrolide A82548A.
Kirst HA; Larsen SH; Paschal JW; Occolowitz JL; Creemer LC; Steiner JL; Lobkovsky E; Clardy J
J Antibiot (Tokyo); 1995 Sep; 48(9):990-6. PubMed ID: 7592067
[TBL] [Abstract][Full Text] [Related]
19. Novel triene-beta-lactone antibiotics, oxazolomycin derivative and its isomer, produced by Streptomyces sp. KSM-2690.
Otani T; Yoshida KI; Kubota H; Kawai S; Ito S; Hori H; Ishiyama T; Oki T
J Antibiot (Tokyo); 2000 Dec; 53(12):1397-400. PubMed ID: 11217805
[No Abstract] [Full Text] [Related]
20. Synthesis and stereochemistry of the terminal spiroketal domain of the phosphatase inhibitor dinophysistoxin-2.
Forsyth CJ; Wang C
Bioorg Med Chem Lett; 2008 May; 18(10):3043-6. PubMed ID: 18226903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
